Blood-Based Biomarkers Aid Early Detection of Alzheimer's Changes

Blood tests such as p-tau217, p-tau181, and amyloid-beta ratios offer less invasive methods to detect biological changes linked to Alzheimer's disease.

Brain changes associated with Alzheimer's disease can begin years before memory loss and other clinical cognitive symptoms appear.

Medical experts clarify that these blood biomarker tests do not directly measure memory loss, brain-cell loss, or cognitive impairment severity.